CROI 2013: Cancer Incidence After Starting Antiretroviral Therapy [VIDEO]


Rates of AIDS-related cancers start to fall not long after initiation of antiretroviral therapy (ART), but non-AIDS cancers rise with increasing time on therapy, according to study findings presented last week at the 20th Conference on Retroviruses and Opportunistic Infections (CROI 2013) in Atlanta.

Elizabeth Yanik from the University of North Carolina at Chapel Hill and colleagues looked at timing and predictors of cancer incidence after starting ART. They found that robust early immunological response is associated with reduced incidence of non-AIDS malignancies caused by viruses, such as anal or cervical cancer caused by human papillomavirus virus (HPV).

[Elizabeth Yanik speaks with Gregory Fowler about cancer incidence, CROI 2013, Atlanta, March 6, 2013]



E Yanik, S Napravnik, S Cole, et al. Timing and Predictors of Cancer Incidence following Initiation of ART: Centers for AIDS Research Network of Integrated Clinical Systems, 1996-2011. 20th Conference on Retroviruses and Opportunistic Infections. Atlanta, March 3-6, 2013. Abstract 141.